Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAssiut University
About this trial
This study aims to validate a prediction model of brain metastasis risk for females with HR+ breast cancer by using variables collected at diagnosis.
Eligibility criteria
Qualifiers
Confirmed diagnosis of HR-positive primary invasive breast cancer.
Disqualifiers
Patients if they were diagnosed with brain metastases at the time of initial breast cancer diagnosis or within the subsequent three months.
Bilateral breast cancer.
Synchronic cancer (i.e., lung cancer, melanoma).
Paitents presenting neurologic symptoms without follow-up or lacking a contrast-enhanced magnetic resonance image (cMRI).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
128 Participants
are grouped into 3 trial groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov